Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Kidney Diseases × trebananib × Clear all

Sponsor

Conditions

Glioblastoma 2 Brain Neoplasms 2 Sarcoma, Endometrial Stromal 1 Sarcoma 1 Prostatic Neoplasms 1 Ovarian Neoplasms 1 Oligodendroglioma 1 Neoplasms 1 Melanoma 1 Kidney Neoplasms 1 Hemangiosarcoma 1 Gliosarcoma 1 Glioma 1 Colorectal Neoplasms 1 Carcinoma, Renal Cell 1

Interventions

Sunitinib 3 avelumab 2 Axitinib 2 spartalizumab 1 pembrolizumab 1 etelcalcetide hydrochloride 1 aldesleukin 1 Sorafenib 1 Plasma Exchange 1 Nutrition Assessment 1 Interleukin-2 1 Adalimumab 1 1-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡